APIActive Pharmaceutical Ingredients

Navigation

Contact Us

Contact Us

Let's connect

Got a query on our products? We shall revert at the earliest

* I agree and accept the Privacy Policy and Terms of Use of this website.

Email us: api@drreddys.com | +91 40 49002253

Events

01 Mar

Meet Our Team at

CPhI Japan Connect

Schedule Meeting

12 Jul

Meet Our Team at

DCAT Week

Schedule Meeting

10 Aug

Meet Our Team at

CPhI North America

Schedule Meeting

11 Oct

Meet Our Team at

CPhI Korea

Schedule Meeting

09 Nov

Meet Our Team at

CPhI Worldwide

Schedule Meeting

16 Dec

Meet Our Team at

CPhI China

Schedule Meeting

Resource Center

Dr. Reddy’s Fosaprepitant API offerings

Dr. Reddy’s Fosaprepitant API offerings

Apixaban API – ready-to-compress granules and finished dosage forms

Apixaban API – ready-to-compress granules and finished dosage forms

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

EMA Nitrosamine Guidance – Deadline March 31, 2021

EMA Nitrosamine Guidance – Deadline March 31, 2021

Colloidal Iron Complex Formulations – Understanding and Developing the Process

Colloidal Iron Complex Formulations – Understanding and Developing the Process

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Best Supply Chain Team of the Year - Pharma- 2021

Best Supply Chain Team of the Year - Pharma- 2021

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

Palbociclib – how a novel process development approach provides IP advantages

Palbociclib – how a novel process development approach provides IP advantages

Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021

Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021